NCT01773889 2018-04-10A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian CancerThe University of Texas Health Science Center at San AntonioPhase 2 Terminated2 enrolled 5 charts